FDAnews Device Daily Bulletin

BAXTER RECEIVES TENTATIVE FDA APPROVALS FOR ONDANSETRON INJECTION IN VIALS AND PREMIX CONTAINERS

June 20, 2006
A A

Baxter Healthcare Corporation today announced that it has received tentative approvals from the U.S. Food and Drug Administration (FDA) for ondansetron injection USP, including the first tentative approval for a premix version of GlaxoSmithKline's Zofran, which is used for the prevention of nausea and vomiting.
Doctor's Guide